| August 1 |
Iomai to Announce Positive Results from Phase 2 Field Trial of Its
Travelers Diarrhea Vaccine and Host Conference Call and Webcast
Tomorrow |
| August 1 |
Success or Failure of Antidepressant Citalopram Predicted by Gene
Variation |
| August 1 |
Phase II Study of Therapeutic Vaccine Shows Efficacy in Patients
with Metastatic Colorectal Cancer |
| August 1 |
Canopus BioPharma's StatC Drug Shows Superior Results for Treatment
of Avian Flu and Other Influenzas |
| August 1 |
Sarasota's Roskamp Institute Releases Study Defining a Mechanism
for Development of Obesity and the Metabolic Syndrome, Forerunners
of Type 2 Diabetes |
| August 2 |
Vidaza Significantly Extends Overall Survival by 74% in Phase 3
Trial in Myelodysplastic Syndromes (MDS) |
| August 2 |
Mayo Clinic News Release: "Wake-Up Pill" Under Study to Treat
Patients with Bipolar Disorder |
| August 2 |
Study provides hope for patients battling obesity and psoriasis |
| August 2 |
Cobalis Reports PreHistin Demonstrates Significant Potential for
Treatment of Vitamin B12 Deficiency |
| August 2 |
Genzyme Announces Second Pivotal Mozobil Trial Meets Primary
Endpoint |
| August 2 |
Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results
of Systemic RNAi Compound for Acute Renal Failure (ARF) |
| August 2 |
Encore Therapeutics Inc. (ETI) Reports Additional Proof of Concept
Results on its Extended Release Ropivacaine Injectable Gel for
Postoperative Pain Management |
| August 2 |
Progesterone Therapy and Preterm Birth: More Evidence Helps
Identify Women Who Can Benefit |
| August 2 |
Pulmonary Fibrosis Mortality Rates Continue to Increase, Especially
in Women |
| August 2 |
Generex Biotechnology to Exhibit At American Association of
Diabetes Educators Annual Meeting & Exhibition |
| August 2 |
Oxford Biomedica: Publication of Trovax Phase II Clinical Trial
Data |
| August 2 |
Side Effects of New Drug for High-Risk Breast Cancer Are Manageable |
| August 2 |
Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF
Inhibitors |
| August 3 |
Landmark Study in The Lancet: Patients Treated With Betaseron After
First MS Attack Experienced Significant Delay in MS Progression |
| August 3 |
Patients Treated with Betaferon After First MS Attack Experienced
Significant Delay in Disability Progession |
| August 6 |
NanoViricides, Inc. Presents at the BARDA Industry Day |
| August 6 |
Molecular Insight Pharmaceuticals, Inc. Selected to Present Zemiva
Phase 2b Clinical Trial Data in Late Breaking Clinical Forum at
American Society of Nuclear Cardiology Annual Meeting |
| August 6 |
MicroDose Announces Positive Results From the QDose Inhaled Insulin
Glucose Clamp Study |
| August 6 |
Apollo’s Trial Success - Needle-free Drug Delivery |
| August 7 |
Arpida Presents a Large Body of Preclinical and Clinical Data at
Scientific Conferences |
| August 7 |
Deflux Significantly Reduces Urinary Tract Infections in Children
With Vesicoureteral Reflux |
| August 7 |
EPIX Pharmaceuticals Announces Positive Results from Phase 2a
Clinical Trial of First-in-Class 5-HT2B Antagonist in Patients with
Pulmonary Hypertension Associated with Chronic Obstructive
Pulmonary Disease |
| August 7 |
Hydra Biosciences Announces Data Revealing the Crucial Role Played
by the TRPA1 Ion Channel in a Standard Model of Pain Receptor
Activation |
| August 7 |
JCEM Publishes Data from OXiGENE-sponsored Preclinical Study of
Combretastatin A4 phosphate / CA4P Triple-Drug Combinations in
Anaplastic Thyroid Cancer |
| August 7 |
Researchers at Cleveland Clinic Identify Site of 'Dysfunction' in
HDL, Carrier of Good Cholesterol |
| August 7 |
Gene Predicts Better Outcome as Cortex Normalizes in Teens with
ADHD |
| August 7 |
Peregrine's Bavituximab HCV Phase Ib Study Results Selected for
Oral Presentation at Upcoming AASLD Annual Meeting |
| August 8 |
FermaVir Announces Positive Data from Recent Preclinical Studies of
FV-100 |
| August 8 |
Genaera Corporation Presents Interim Phase 1 Data for Obesity
Compound Trodusquemine (MSI-1436) at IBC Conference |
| August 8 |
CytoDyn DNA Vaccine Shows Promise for Low-Dose Protection from Bird
Flu, Reliable Supply |
| August 8 |
Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study |
| August 8 |
Phosphagenics Announces Positive Phase 1b Transdermal Insulin
Clinical Trial Results |
| August 9 |
Genaera Corporation Presents Interim Phase 1 Data for Obesity
Compound Trodusquemine (MSI-1436) at IBC Conference |
| August 9 |
Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects
Vaccinated With Novel Travelers' Diarrhea Patch Vaccine |
| August 9 |
InNexus Biotechnology to Host Teleconference/Web Cast Outlining
Recently Launched Pre-Clinical Candidate DXL625 (CD20) |
| August 9 |
Prophylactic Use of Recombinant Factor VIII Prevents Joint Disease
in Young Boys with Hemophilia A |
| August 9 |
Obesity Linked to Hyperparathyroidism in Chronic Kidney Disease |
| August 9 |
DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for
DOV 21,947 |
| August 13 |
Positive Kuvan Pivotal Phase 3 Trial Results Published in The
Lancet |
| August 13 |
Newly Published Research Indicates the Potential of Phenoxodiol to
Protect Against Neuropathy |
| August 14 |
Idera Pharmaceuticals Announces Publication of Preclinical Data on
Toll-Like Receptor 7 and 8 Agonists |
| August 14 |
Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell
DNA Repair Mechanisms |
| August 14 |
Phase II Clinical Trial Results for Adentri Published in Journal of
the American College of Cardiology |
| August 14 |
BrainStorm Cell Therapeutics on the Road to Clinical Studies in
Parkinson's Disease |
| August 14 |
Oramed Pharmaceuticals Successfully Completes Phase 1A Trials |
| August 14 |
NeurAxon Announces Positive Phase 1 Trial Data on NXN-188 for
Migraine |
| August 14 |
Generex Biotechnology Announces Publication of Generex Oral-Lyn
Study Results in Diabetes Technology & Therapeutics |
| August 15 |
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded
Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of
SinuNase for the Treatment of Refractory Chronic Sinusitis |
| August 15 |
Novavax Announces Publication of HIV/AIDS Vaccine Research in
Journal of Virology |
| August 16 |
Cephalon Announces Positive Results from a Pivotal Study of Fentora
in Opioid-tolerant Patients with Non-cancer Breakthrough Pain |
| August 16 |
Novel Technology Breaks Through Cancer Pain |
| August 16 |
Study Reports Epratuzumab Affects B-Cells from Patients With Lupus
in a Unique Manner |
| August 17 |
MediciNova Reports Phase Ib Clinical Study Results for MN-221, a
Novel Treatment for Preterm Labor |
| August 17 |
Management to Make Two Presentations on the Topic of Drug
Repurposing and Indian Clinical Trial Strategy |
| August 20 |
Intellect Neurosciences, Inc. to Present Data on Alzheimer's
Vaccine at 13th International Congress of Immunology Conference |
| August 20 |
PNH Patients Treated with Soliris Experienced Dramatic Reduction in
Blood Clots During Clinical Trials |
| August 20 |
Dendreon Announces Publication of Phase 1 Study Highlighting
Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge) in
Advanced Breast Cancer Patients |
| August 20 |
Adnexus Therapeutics to Present Data on Adnectin Product Candidate,
CT-322, at Gordon Research Conference |
| August 20 |
Tysabri Demonstrates Significant Health-Related Quality-of-Life
Improvements for Multiple Sclerosis Patients in Study Published in
Annals of Neurology |
| August 20 |
Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate,
Sphingomab, in Non-Human Primates |
| August 20 |
Metabasis Therapeutics Presents Preclinical Results Demonstrating
Potential Advantages of MB07811 as a Treatment for Hyperlipidemia |
| August 20 |
Can-Fite Successfully Completes Preclinical Trials With Its Second
Drug Candidate CF102 |
| August 20 |
Intercell’s Therapeutic Hepatitis C Vaccine Meets Primary
Endpoints in Phase II Interim Analysis |
| August 21 |
New Data Suggest Cymbalta Reduced Pain in Fibromyalgia Patients
With and Without Depression |
| August 21 |
Nymox Announces New Clinical Data from BPH Drug Trials to Be
Presented at Upcoming U.S. Urology Meeting |
| August 22 |
CV Therapeutics Announces Eight Abstracts Accepted for Presentation
at the European Society of Cardiology Congress 2007 |
| August 22 |
Merck Serono Announces 18-Month Safety and Efficacy Dataof Phase
III Trial of Safinamide in Parkinson's Disease |
| August 22 |
Two Separate Studies Presented at the AIDS Vaccine 2007 Conference
Show Improved Results with the Biojector(R)2000 |
| August 22 |
SemBioSys Updates Apo AI Development Program |
| August 22 |
Lexicon Presents Class of Compounds Modulating TPH1, the Target for
its LX1031 Investigational Drug for Irritable Bowel Syndrome |
| August 22 |
Data on PolyMedix Antimicrobial Polymers Being Presented at Annual
Meeting of the American Chemical Society |
| August 22 |
Paper in International Journal of Oncology Reports Alfacell's
Onconase Suppresses Intracellular Oxidative Stress |
| August 23 |
ProNAi Therapeutics Announces First DNAi Mechanism of Action
Studies for PNT2258 Oncology Drug Candidate |
| August 23 |
Poniard Pharmaceuticals to Present Updated Results of Picoplatin
Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on
Lung Cancer |
| August 23 |
Encouraging Phase II Data on HIV Vaccine Utilizing GenVec
Technologies Presented at Seattle AIDS Conference |
| August 23 |
Iomai Announces Data from Phase 2 Field Study of Travelers'
Diarrhea Vaccine Accepted for Presentation at ICAAC |
| August 23 |
CollaGenex Pharmaceuticals Announces Highly Positive Results of
Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema |
| August 23 |
Opexa to Present Proprietary T-Cell Technology at Vaccine
Conference on August 24, 2007 |
| August 23 |
ReGen Therapeutics Plc - Research Update |
| August 23 |
Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology
Produce Encouraging Results |
| August 23 |
ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern
Time to Provide Update on rThrombin |
| August 23 |
Paper in Advances in Experimental Medicine and Biology Reports
Alfacell's Onconase Enhances Effect of Radiation in Non-Small Cell
Lung Cancer |
| August 23 |
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent
Among High-Risk Native American, Full-Term Infants in
Placebo-Controlled Phase 3 study |
| August 24 |
Avicena Scientific Collaborator Advances Program for Using Energy
Enhancing Molecules to Treat Neuromuscular Diseases |
| August 27 |
Ascenta Therapeutics Presents New Clinical Data on AT-101 for the
Treatment of Hormone-Refractory Prostate Cancer |
| August 27 |
Nexavar Significantly Improved Overall Survival in Phase 3
Asia-Pacific Liver Cancer Trial |
| August 27 |
New Data Highlights Long Term Tolerability and Sustained Benefits
of the Exelon Patch in the Treatment of Alzheimer’s Disease |
| August 27 |
New Study May Explain Vioxx Side-effects |
| August 27 |
Adnexus Therapeutics Announces Additional Phase I and Preclinical
Data on CT-322 at 6th International Congress on Targeted Therapies
in Cancer |
| August 27 |
Actelion to Discuss Results from the Early, Compass-1, Future and
Benefit Studies Presented at the European Society of Cardiology
Congress |
| August 27 |
Actelion to announce results from 'proof-of-concept'/dose ranging
study of its novel orexin receptor antagonist during the 2007 World
Sleep Congress |
| August 27 |
Is it Safe to Use Oral Contraceptives to Eliminate Periods? Harvard
Women's Health Watch Explores the Question |
| August 27 |
Cleveland Clinic Researchers Identify Mechanism Behind Platelet
Function and Potentially Fatal Blood Clot Formation |
| August 27 |
ImmuneRegen BioSciences, Inc. Demonstrates Radilex Increases
Disease-Fighting White Blood Cells |
| August 27 |
Geron Scientists and Collaborators Demonstrate Human Embryonic Stem
Cell-Derived Cardiomyocytes Improve Heart Function When
Transplanted After Myocardial Infarction |
| August 27 |
NIH Scientists Discover Novel Cause of Iron Overload in Thalassemia
Disorders |
| August 28 |
Antares Pharma Will Present Anturol at the 28th Annual Scientific
Meeting of the American Urogynecologic Society |
| August 28 |
Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in
Indonesia in 2006 |
| August 28 |
Evotec to Present Details of the Positive Phase II Study in
Insomnia With EVT 201 at the Worldsleep07 Congress in
Cairns/Australia |
| August 28 |
New Kaiser Permanente Study Shows Treating Diabetes During
Pregnancy Can Break Link to Childhood Obesity |
| August 28 |
Allergy Patients Treated with PreHistin Had Rise in Ragweed IgE
Antibodies Blunted During Pollen Season |
| August 28 |
Prodest Study Shows Many Parkinson’s Disease Patients
Continue to Experience PD-Related Depressive Symptoms Despite
Receiving Anti-Depressant Treatment |
| August 28 |
Journal of American College of Cardiology Publishes Positive
Findings on Generx Now in Phase 3 for Heart Disease |
| August 29 |
Phase III Trial Finds Pharmaxis' Bronchitol Effective |
| August 29 |
I-Flow Corporation Announces That Results of ON-Q Colorectal Study
Will Be Presented at Infectious Diseases Conference in September |
| August 29 |
Boston Scientific Announces Schedule for European Society of
Cardiology Congress 2007 |
| August 29 |
Experimental Drug Ketasyn Improves Memory in Age-Associated Memory
Impairment Study |
| August 29 |
New Data on AtheroGenics AGI-1067 Accepted for Presentation at the
European Society of Cardiology Congress 2007 |
| August 29 |
Another Step on the Journey to Hope for MDS Patients: New Study
Demonstrates Survival Benefit in Patients with MDS (myelodysplastic
syndromes) |
| August 30 |
Genzyme Announces Publication of DCOR Study in Kidney International |
| August 30 |
St. Jude Discovers Factors That Accelerate Resistance to Gleevec
Targeted Therapy in Lymphoblastic Leukemia |
| August 30 |
Transition Therapeutics Announces Completion of Phase I Clinical
Studies with Alzheimer's Disease Drug Candidate ELND-005/AZD-103 |
| August 30 |
Pharming Presents Positive Results from European Phase III Trial of
Rhucin |
| August 30 |
Obecure Phase II Trial Shows Positive Results For Histalean In
Obese Women Under 50 |
| August 30 |
Mayo Clinic Research Shows Estrogen Protects Women's Brains Prior
to Menopause; Ovary Removal Before Menopause Increases Risk of
Parkinson's Disease and Parkinsonism |
| August 31 |
Kiadis Pharma Announces Promising Phase II Clinical Trial Results
for Reviroc |
| August 31 |
STA-4783 Data to be Presented at the First Worldwide Melanoma
Center Meeting of the European Association of Dermato-Oncology |
| August 31 |
Discovery Suggests Location of Genes for Breast Density, a Strong
Risk Factor for Breast Cancer |
